Clinical Trials Browser

Neoplasm, Residual × Trastuzumab × Clear all

NCT06663787 2025-11-28

HER2 CR

Active not recruiting

Breast Neoplasms, Neoplasm Metastasis, Neoplasm, Residual

NCT01401959 2018-06-15

Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy

Phase 2 Completed

127 enrolled 11 charts

Breast Neoplasms, Neoplasm, Residual